Adotrastuzumab emtansine
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Adotrastuzumab emtansine, covering 2022-01-11 to 2022-01-11. Get the full timeline:
Most recent: Clinical Trial Update: BN-Brachyury, Entinostat, Adotrastuzumab Emtansine and M7824 in Advanced Stage Breast Cancer (BrEAsT) [Phase 1]